The U.S. Food & Drug Administration said on Friday it had approved Eli Lilly's (NYSE:LLY) injection to help improve blood sugar control in adults with type 2 diabetes.
>>> Read the full story at Latest Financial and Investing News — TradingView
U.S. FDA approves Eli Lilly’s treatment for type 2 diabetes
